Paper378369
Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations.
Davis HL and 1 other. Cancer Treat Rep, 1979. Cited by 88 papers, by iCite.
Cite this record
ConductScience Library. Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations. Papers, record 378369. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/378369
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Daunorubicin | Major topic |
| Doxorubicin | Major topic |
| Neoplasms | Major topic |
| Breast Neoplasms | |
| Drug Therapy, Combination | |
| Hodgkin Disease | |
| Humans | |
| Leukemia | |
| Lymphoma | |
| Sarcoma | |
| Soft Tissue Neoplasms |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38700665 | Assessment of Native Myocardial T1 Mapping for Early Detection of Anthracycline-Induced Cardiotoxicity in Patients with Cancer: a Systematic Review and Meta-analysis. | Cardiovasc Toxicol | 2024 | https://conductscience.org/library/papers/38700665 | PubMed |
| 36816668 | Tandem Protocol of Hexahydroquinoline Synthesis Using [H2-DABCO][HSO4]2 Ionic Liquid as a Green Catalyst at Room Temperature. | ACS Omega | 2023 | https://conductscience.org/library/papers/36816668 | PubMed |
| 24277182 | Pharmacokinetics of anthracyclines in dogs: evidence for structure-related body distribution and reduction to their hydroxy metabolites. | Pharm Res | 1984 | https://conductscience.org/library/papers/24277182 | PubMed |
| 23508666 | N-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: from preclinical data to clinical evidence. | Eur J Clin Pharmacol | 2013 | https://conductscience.org/library/papers/23508666 | PubMed |
| 18451141 | Genetic variants contributing to daunorubicin-induced cytotoxicity. | Cancer Res | 2008 | https://conductscience.org/library/papers/18451141 | PubMed |
| 17545624 | Mapping genes that contribute to daunorubicin-induced cytotoxicity. | Cancer Res | 2007 | https://conductscience.org/library/papers/17545624 | PubMed |
| 7425613 | Biosynthesis of daunorubicin glycosides: role of epsilon-rhodomycinone. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7425613 | PubMed |
| 6961377 | Anthracycline cardiomyopathy. | Pediatr Cardiol | 1982 | https://conductscience.org/library/papers/6961377 | PubMed |
| 6819097 | Effect of cyclophosphamide pretreatment on the short-term disposition and biliary excretion of adriamycin metabolites in rat. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6819097 | PubMed |
| 6574828 | A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6574828 | PubMed |
| 6189661 | Clinical pharmacokinetics of commonly used anticancer drugs. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6189661 | PubMed |
| 3860797 | Aspects of the chemical stability of doxorubicin and seven other anthracyclines in acidic solution. | Pharm Weekbl Sci | 1985 | https://conductscience.org/library/papers/3860797 | PubMed |
| 3730255 | Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumvention. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3730255 | PubMed |
| 3698178 | A rapid chromatographic procedure for the determination of adriamycin, daunomycin and their 13-OH metabolites adriamycinol and daunomycinol. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3698178 | PubMed |
| 3555940 | Pharmacokinetics of anticancer drugs in children. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3555940 | PubMed |
| 3520474 | Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties. | Pharm Weekbl Sci | 1986 | https://conductscience.org/library/papers/3520474 | PubMed |
| 3459509 | The in vitro effects and cross-resistance patterns of some novel anthracyclines. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3459509 | PubMed |
| 3359560 | Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicin. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3359560 | PubMed |
| 3358904 | Doxorubicin cellular pharmacokinetics and DNA breakage in a multi-drug resistant B16 melanoma cell line. | Br J Cancer | 1988 | https://conductscience.org/library/papers/3358904 | PubMed |
| 3223881 | SEM observations on the effect of anthracycline drugs on cultured newborn rat cardiomyocytes. | Basic Res Cardiol | 1988 | https://conductscience.org/library/papers/3223881 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/378369
GET https://conductscience.org/api/papers/v1/378369/cited_by?page=2